The Clorox Company
CLX · NYSE
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $7,104,000 | $7,093,000 | $7,389,000 | $7,107,000 |
| % Growth | 0.2% | -4% | 4% | – |
| Cost of Goods Sold | $3,910,000 | $4,068,000 | $4,518,000 | $4,616,000 |
| Gross Profit | $3,194,000 | $3,025,000 | $2,871,000 | $2,491,000 |
| % Margin | 45% | 42.6% | 38.9% | 35% |
| R&D Expenses | $121,000 | $126,000 | $138,000 | $132,000 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1,894,000 | $1,983,000 | $1,905,000 | $1,663,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2,015,000 | $2,109,000 | $2,044,000 | $1,795,000 |
| Operating Income | $1,179,000 | $916,000 | $827,000 | $696,000 |
| % Margin | 16.6% | 12.9% | 11.2% | 9.8% |
| Other Income/Exp. Net | -$101,000 | -$518,000 | -$589,000 | -$89,000 |
| Pre-Tax Income | $1,078,000 | $398,000 | $238,000 | $607,000 |
| Tax Expense | $254,000 | $106,000 | $77,000 | $136,000 |
| Net Income | $810,000 | $280,000 | $149,000 | $462,000 |
| % Margin | 11.4% | 3.9% | 2% | 6.5% |
| EPS | 6.56 | 2.25 | 1.21 | 3.75 |
| % Growth | 191.6% | 86% | -67.7% | – |
| EPS Diluted | 6.52 | 2.25 | 1.2 | 3.73 |
| Weighted Avg Shares Out | 123,525 | 124,174 | 123,589 | 123,113 |
| Weighted Avg Shares Out Dil | 124,287 | 124,804 | 124,181 | 123,906 |
| Supplemental Information | – | – | – | – |
| Interest Income | $9,000 | $23,000 | $16,000 | $5,000 |
| Interest Expense | $101,000 | $103,000 | $103,000 | $97,000 |
| Depreciation & Amortization | $219,000 | $235,000 | $236,000 | $224,000 |
| EBITDA | $1,398,000 | $736,000 | $577,000 | $928,000 |
| % Margin | 19.7% | 10.4% | 7.8% | 13.1% |